➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Merck
Medtronic
Mallinckrodt
AstraZeneca

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 8,808,225

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,808,225
Title:Methods and devices for drug delivery to ocular tissue using microneedle
Abstract: Methods and devices are provided for targeted administration of a drug to a patient\'s eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.
Inventor(s): Prausnitz; Mark R. (Atlanta, GA), Edelhauser; Henry F. (Atlanta, GA), Patel; Samirkumar Rajnikant (Atlanta, GA)
Assignee: Emory University (Atlanta, GA) Georgia Tech Research Corporation (Atlanta, GA)
Application Number:13/447,246
Patent Claims:see list of patent claims

Details for Patent 8,808,225

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Emory University (Atlanta, GA) Georgia Tech Research Corporation (Atlanta, GA) 2026-05-02 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Emory University (Atlanta, GA) Georgia Tech Research Corporation (Atlanta, GA) 2026-05-02 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Emory University (Atlanta, GA) Georgia Tech Research Corporation (Atlanta, GA) 2026-05-02 RX Orphan search
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30   Start Trial Emory University (Atlanta, GA) Georgia Tech Research Corporation (Atlanta, GA) 2026-05-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Mallinckrodt
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.